Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom

New therapeutic options in breast cancer have improved survival but consequently increase the relevance of late complications. Ovarian suppression/ablation and aromatase inhibitors (AI) in the adjuvant setting have improved outcome, but have clinically important adverse effects on bone health. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lester, J E, Dodwell, D, Horsman, J M, Mori, S, Coleman, R E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361086/
https://www.ncbi.nlm.nih.gov/pubmed/16317429
http://dx.doi.org/10.1038/sj.bjc.6602892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361086/
https://www.ncbi.nlm.nih.gov/pubmed/16317429
http://dx.doi.org/10.1038/sj.bjc.6602892

Ejemplares similares